Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample-Reference-Cited by-同舟云学术

Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample

Published:2024-07-11 Issue:5 Volume:37 Page:804-812
ISSN:0899-8280
Container-title:Baylor University Medical Center Proceedings
language:en
Short-container-title:Baylor University Medical Center Proceedings

Author:

El-amir Zain¹^ORCID,Jamil Abdur²,Solanki Dhanshree³,Mansuri Uvesh⁴,Mathew Midhun⁵,Singh Jagmeet⁶,Aslam Shehroz²,Akram Hamza²,Mandal Shobha⁷,Kichloo Asim²

Affiliation:

1. Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA

2. Division of Internal Medicine, Samaritan Medical Center, Watertown, New York, USA

3. Research Update Organization, Houston, Texas, USA

4. Department of Medicine, Medstar Harbor Hospital, Baltimore, Maryland, USA

5. Virtua Hospitalists, Marlton, New Jersey, USA

6. Division of Nephrology, Guthrie Robert Packer Hospital, Sayre, Pennsylvania, USA

7. Hospitalist Department, Guthrie Robert Packer Hospital, Sayre, Pennsylvania, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08998280.2024.2375688

Reference42 articles.

1. Malignant lymphomas in transplantation patients;Penn I;Transplant Proc,1969

2. Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

3. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

4. Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

5. Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients